Patent Assignment
Reel/Frame 031125/0597
Change of Name
Recorded: 2013-08-30
Pages: 4
Assignor
NEOPROBE CORPORATION
Executed: 2011-12-13
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
425 METRO PLACE NORTH, SUITE 300, DUBLIN, OHIO, 43017
Covered Property
(1)
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Release of Security Interest
Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →
Assignment of Assignor's Interest
Mar 20, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 041645/0574 →